º´¸®ÇÐȸ, Á¶±¹ µþ ³í¹® Ãë¼Ò °áÁ¤!

Á¶±¹¾¾³ª ºÎÀÎÀº, µþÀÇ ÓÞìýéÄ ½ºÆåÀ» ½×±â À§ÇÏ¿© ³í¹® ÀúÀÚ Á¶ÀÛ¿¡ °¡´ã, ¿©·¯ »ç¶÷µéÀÇ Ò¾ÍȰ¡ ±êµç ³í¹®°ú ¿¬±¸¼º°ú¸¦ ¸ÁÃÆ´Ù´Â ³í¶õÀ» ÇÇÇÒ ¼ö°¡ ¾ø°Ô µÇ¾ú´Ù.
´ëÇѺ´¸®ÇÐȸ°¡ 5ÀÏ Á¶±¹ ¹ý¹«ºÎ Àå°ü Èĺ¸ÀÚ µþ Á¶¹Î(28)¾¾°¡ Á¦1îÊíº·Î µîÀçµÈ º´¸®ÇÐ ³í¹®À» òÅÏíÀ¸·Î Ãë¼ÒŰ·Î ÃÖÁ¾ °áÁ¤Çß´Ù. ´ëÇѺ´¸®ÇÐȸ´Â Çмú ÆíÁýÀ§¿øÈ¸¸¦ ¿­°í "¿¬±¸À±¸® À§¹ÝÀÌ ÀÎÁ¤µÅ ³í¶õÀÌ µÈ Á¦1ÀúÀÚ ³í¹®À» Ãë¼ÒÇϱâ·Î °áÁ¤Çß´Ù"°í ¹ßÇ¥ÇÏ¿´´Ù. ¹®Á¦°¡ µÈ ³í¹®Àº 2009³â 3¿ù ´ëÇѺ´¸®ÇÐȸÁö¿¡ ½Ç¸° ¡®Ãâ»ê îñý­ ÇãÇ÷¼º Àú»ê¼Ò ³úº´Áõ¿¡¼­ ³ªÅ¸³ª´Â eNOS À¯ÀüÀÚÀÇ ´ÙÇü¼º(eNOS Gene Polymorphisms in Perinatal Hypoxic-Ischemic Encephalopathy)¡¯ÀÌ´Ù.
³í¹® Ãë¼Ò »çÀ¯´Â Å©°Ô ¼¼ °¡Áö´Ù. ´ëÇѺ´¸®ÇÐȸ´Â ¡â¿¬±¸À±¸®½ÉÀÇÀ§¿øÈ¸(IRB) ½ÂÀÎÀ» ¹ÞÁö ¾ÊÀº Á¡ ¡âIRB ½ÂÀÎÀ» ¹ÞÁö ¾Ê¾ÒÀ½¿¡µµ ½ÂÀÎ ¹Þ¾Ò´Ù°í ÇãÀ§ ±âÀçÇÑ °Í ¡â³í¹® Á¦1ÀúÀڷμ­ÀÇ îÊíº ¿ªÇÒÀÌ ºÐ¸íÄ¡ ¾ÊÀº Á¡.

´Ü±¹´ë Áöµµ±³¼ö À念ǥ ±³¼ö´Â ¼Ò¸í¼­¸¦ ÅëÇØ ¡®îÊíº ¿ªÇÒÀÇ ºÎÀûÀý¼º¡¯À» ÀÎÁ¤Çß´Ù. Àå¼¼Áø º´¸®ÇÐȸ ÀÌ»çÀåÀº "´ç½Ã ³í¹®¿¡¼­ ÀúÀÚµéÀÇ ¿ªÇÒÀÌ ºÐ¸íÄ¡ ¾ÊÀº °ÍÀ» À念ǥ ±³¼ö º»Àεµ ½ÃÀÎÇß´Ù"¸é¼­ "ÀÌ¿¡ µû¶ó ¿¬±¸ºÎÁ¤ÇàÀ§·Î ÀÎÁ¤µÅ ³í¹® Ãë¼Ò·Î °áÁ¤Çß´Ù"°í ¸»Çß´Ù. À̾î "IRB ÇãÀ§ ±âÀç·Î ÀÎÇØ ¿¬±¸ °úÁ¤°ú °á°ú¿¡ ´ëÇÑ ½Å·Ú¼ºµµ ´ãº¸ÇÒ ¼ö ¾ø´Ù"°í µ¡ºÙ¿´´Ù. º´¸®ÇÐȸ´Â ÆíÁýÀ§ ȸÀÇ¿¡¼­ ¡®¿¬±¸ ºÎÁ¤ ÇàÀ§¡¯°¡ ÀÎÁ¤µÆ´Ù°í °áÁ¤Çß´Ù.

´ç½Ã °íµîÇлýÀÌ´ø Á¶ Èĺ¸ÀÚ µþ Á¶¾¾°¡ ¼Ò¼Ó Ç¥±â¸¦ ºÎÁ¤È®ÇÏ°Ô ÇÑ Á¡µµ ÁöÀûÇß´Ù. º´¸®ÇÐȸ ÃøÀº "´ç½Ã ±ÔÁ¤¿¡´Â ¾øÀ¸³ª 2012³â ±³À°°úÇбâ¼úºÎ ÈÆ·ÉÀ¸·Î ºÎ´çÇÑ ³í¹®ÀúÀÚ Ç¥½Ã¸¦ ¶Ç ÇϳªÀÇ ¿¬±¸ºÎÁ¤ÇàÀ§·Î Á¤Çϰí ÀÖ´Ù"¸é¼­ "³í¹®¿¡ ¿¬±¸ ¼öÇà±â°ü°ú ñ«¼Ò¼Ó ±â°ü(°íµîÇлý)À» ܱÑÀÇÏ´Â °ÍÀÌ ÀûÀýÇß´Ù"°í ¹àÇû´Ù.

´Ù¸¸ ¿¬±¸ ³»¿ë¿¡ ´ëÇÑ ÇмúÀûÀÎ ¹®Á¦°¡ ÀÖ´ÂÁö ¿©ºÎ¿¡ ´ëÇØ¼­´Â ¡®¾ø´Ù¡¯°í °á·Ð³Â´Ù. Àå ÀÌ»çÀåÀº "IRB ½ÂÀÎÀÌ ÇãÀ§ ±âÀçµÈ ³í¹®À̹ǷΠ¿¬±¸ÀÇ ÇмúÀû ¹®Á¦´Â ÆÇ´Ü ´ë»óÀÌ µÇÁö ¾Ê´Â´Ù"°í ¼³¸íÇß´Ù. Á¶ Èĺ¸ÀÚ µþ ÀÇÇÐ ³í¹® Ã¥ÀÓÀúÀÚÀÎ À念ǥ ´Ü±¹´ë ÀÇ´ë ±³¼ö´Â ´ëÇѺ´¸®ÇÐȸ Ãø¿¡ À̳¯ ¿ÀÈÄ 2½Ã ¼Ò¸í(áÂÙ¥)¾ÈÀ» À̸ÞÀÏ·Î Á¦ÃâÇß´Ù. ÇÐȸ°¡ ¿ä±¸ÇÑ °ÍÀº ¡â¿¬±¸À±¸®½ÉÀÇÀ§¿øÈ¸(IRB) ÇãÀ§ ±âÀç ¡âÁ¶¾¾ÀÇ ¼Ò¼Ó ±âÀç ¿À·ù ¡âÁ¶¾¾ÀÇ Á¦1ÀúÀڷμ­ÀÇ ¿ªÇÒ µîÀ̾ú´Ù. ¼Ò¸í¾ÈÀ» Á¢¼öÇÑ º´¸®ÇÐȸ´Â À̳¯ »óÀÓÀÌ»çȸ¿¡ ÀÌ¾î ÆíÁýÀ§¿øÈ¸¸¦ °ÅÃÄ ³í¹® Ãë¼Ò¸¦ °áÁ¤Çß´Ù.

Á¶±¹¾¾³ª ºÎÀÎÀº, µþÀÇ ÓÞìýéÄ ½ºÆåÀ» ½×±â À§ÇÏ¿© ³í¹® ÀúÀÚ Á¶ÀÛ¿¡ °¡´ã, ¿©·¯ »ç¶÷µéÀÇ Ò¾ÍȰ¡ ±êµç ³í¹®°ú ¿¬±¸¼º°ú¸¦ ¸ÁÃÆ´Ù´Â ³í¶õÀ» ÇÇÇÒ ¼ö°¡ ¾ø°Ô µÇ¾ú´Ù.

³í¹®ÀÌ Á÷±Ç Ãë¼ÒµÇ¸é¼­ Á¶¾¾ÀÇ °í·Á´ë ÀÔÇеµ Ãë¼ÒµÉ ¼ö ÀÖ´Ù. Á¶¾¾´Â 2010Çг⵵ °í·Á´ë ÀԽà ¶§ Á¦ÃâÇÑ ÀÚ±â¼Ò°³¼­¿¡ ¡®´Ü±¹´ëÇб³ ÀÇ·á¿ø ÀǰúÇÐ ¿¬±¸¼Ò¿¡¼­ÀÇ ÀÎÅÏ½Ê ¼º°ú·Î ³ªÀÇ À̸§ÀÌ ³í¹®¿¡ ¿À¸£°Ô µÇ¾ú´Ù¡¯°í ½è´Ù.
Áö³­´Þ 21ÀÏ °í·Á´ë´Â ¡®¹ý¹«ºÎÀå°ü Èĺ¸ÀÚ ÀÚ³à °í·Á´ë ÀÔÇÐ °ü·Ã ³í¶õ¿¡ ´ëÇÑ ÀÔÀå¹®¡¯À» ³»°í "ÃßÈÄ Á¶¾¾¿¡ ´ëÇÑ Á¶»ç¿¡ µû¶ó ÀÔÇÐÃë¼Ò 󸮰¡ µÉ ¼ö ÀÖ´Ù"°í ¹àÇû´Ù. °í·Á´ë´Â ¶Ç "³í¹®ÀÇ ÇÏÀÚ°¡ ¹ß°ßµÇ¸é Á¶¾¾¸¦ ¼­¸é ¶Ç´Â Ãâ¼®Á¶»çÇØ Çлç¿î¿µ±ÔÁ¤ Á¦8Á¶¿¡¼­ ±ÔÁ¤µÈ ÀÔÇÐÃë¼Ò»çÀ¯ ´ë»óÀÚÀÎ ¡®ÀÔÇлçÁ¤À» À§ÇÏ¿© Á¦ÃâÇÑ ÀüÇüÀÚ·á¿¡ Áß´ëÇÑ ÇÏÀÚ°¡ ¹ß°ßµÈ °æ¿ì¡¯¿¡ ÇØ´çÇÏ´ÂÁö °ËÅäÇϰڴٰí"µµ Çß´Ù.

°í·Á´ë ÀÔÇÐÀÌ Ãë¼ÒµÉ °æ¿ì, °í·Á´ë Á¹¾÷À» ÀüÁ¦·Î ÇÑ ºÎ»ê´ë ÀÇÀü¿ø ÀÔÇеµ ÀÚ¿¬½º·´°Ô ¹«È¿°¡ µÉ ¼ö ÀÖ´Ù. ºÎ»ê´ë °ü°èÀÚ´Â "ÀԽÿ䰭¿¡ ¸í½ÃµÈ °Íó·³ ºÎ»ê´ë ÀÇÀü¿ø¿£ ¡®´ëÇлý¡¯¸¸ Áö¿øÇÒ ¼ö ÀÖ´Ù"¸ç "°í·Á´ë ÇÐÀ§°¡ Ãë¼ÒµÇ¸é ºÎ»ê´ë ÀÔÇеµ ¹«È¿°¡ µÈ´Ù"°í Çß´Ù. ±³¼ö ÀÚ³àÀÇ ³í¹® ¹®Á¦·Î ÀÔÇÐÀÌ Ãë¼ÒµÈ »ç·Êµéµµ ÀÖ´Ù. 2013³â ÇѾç´ë¿¡¼­ Àǰú´ëÇÐÀå °â ÀÇÀü¿øÀåÀÌ ÀÚ½ÅÀÇ ¾ÆµéÀ» SCI±Þ ³í¹®ÀÇ Á¦1ÀúÀÚ·Î ¿Ã¸®°í ´Ù¸¥ ÀúÀÚÀÇ À̸§À» ´©¶ô½ÃŲ »ç½ÇÀÌ µå·¯³ª, ±³¼ö º»ÀÎÀº ±³¼öÁ÷¿¡¼­ ¹°·¯³ª°í, ¾Æµéµµ ÀÚÅðÇß´Ù. Áö³­´Þ¿¡´Â ±³¼öÀÎ ¾î¸Ó´ÏÀÇ µµ¿òÀ¸·Î ´ëÇпø»ýµéÀÌ ¼öÇàÇÑ ¿¬±¸¸¦ °¡·Îä ¼­¿ï´ë Ä¡ÀÇÇÐÀü¹®´ëÇпø¿¡ ÇÕ°ÝÇß´ø ÇлýÀÇ ÀÔÇÐÀÌ Ãë¼ÒµÇ±âµµ Çß´Ù.

*¾îÁ¦ ´ëÇѼҾÆÃ»¼Ò³â°úÀÇ»çȸ ±âÀÚȸ°ß ¹ßÇ¥¹®: "ÇØ´ç ³í¹®Àº 3kg ¹Û¿¡ ¾ÈµÇ´Â ½Å»ý¾Æµé ±×°Íµµ ÀϺδ ¾ÆÇ ¾ÆÀ̵é ÇǸ¦ »Ì¾Æ¼­ ÀÛ¼ºµÈ °ÍÀÔ´Ï´Ù. ÀÌ·± °¡¿©¿î ¾ÆÀ̵éÀÇ ¼ÒÁßÇÑ Çǰ¡ ¾ÆÇ ¾ÆÀ̵éÀ» ³´°ÔÇÒ Áø¸®¸¦ ã´Âµ¥ ¾²ÀÎ °ÍÀÌ ¾Æ´Ï¶ó ¾î´À ÈûÀÖ°í µ·¸¹Àº ÀÚÀÇ ÀÚ½ÄÀÇ ´ëÇÐÀԽø¦ À§ÇØ ÇԺηΠ¾²¿´´Ù´Â µ¥¼­ ¾ÆÇ ¾ÆÀ̵éÀ» °íÃÄÁÖ´Â °ÍÀ» Æò»ýÀÇ ³«À¸·Î »ï°í »ì¾Æ¿Ô´ø ¼Ò¾ÆÃ»¼Ò³â°ú ÀÇ»ç·Î¼­ Àú´Â ÂüÀ» ¼ö ¾ø´Â ºÐ³ë¸¦ ´À³§´Ï´Ù. ½Ç·Â¾ø´Â ÀÇ»ç´Â ȯÀÚÀÇ ¸ñ¼ûÀ» ¾Ñ¾Æ °©´Ï´Ù. µû¶ó¼­ ÀÇ´ë ºÎÁ¤ÀԽô ´Ü¼ø ºÎÁ¤ÀԽÿ¡ ±×Ä¡´Â °ÍÀÌ ¾Æ´Ï¶ó ´Ù¸¥ »ç¶÷ÀÇ ¸ñ¼û±îÁö À§ÅÂ·Ó°Ô ¸¸µå´Â ¹üÁËÇàÀ§ÀÔ´Ï´Ù."

Á¶±¹¾¾°¡ ¹ý¹«Àå°üÀÌ µÇ°Ú´Ù´Â °ÍÀº µµµÏÀÌ µµµÏÀ» Àâ°Ú´Ù°í ¶°µå´Â °Í°ú ¸¶Âù°¡Áö¶ó°í »ý°¢ÇÕ´Ï´Ù. Á¶±¹¾¾´Â ÃÖ¼ÒÇÑÀÇ ¾ç½ÉÀÌ ÀÖ´Ù¸é ¿À´Ã ´çÀå »çÅðÇϱ⠹ٶø´Ï´Ù.


///////////////////////////////////////////////////////////////////////////
*³í¹®ÀÇ ôüÖâ ù ¹®Àå¿¡ è¦í®

Á¶±¹ Èĺ¸ÀÚÀÇ µþÀÌ ÇÑ¿µ¿Ü°í ½ÃÀý 2ÁÖ°£ ÀÎÅÏÀ¸·Î Âü¿©ÇØ Á¦1ÀúÀÚ·Î µîÀçµÈ ³í¹®À» Á¶±Ý ¹ø¿ªÇغôÙ. ³»¿ëÀÌ ¾î·Á¿î °ÍÀº µÑ°ġ°í ¿ÀÅ»ÀÚ¿Í ¾î»öÇÑ Ç¥ÇöÀÌ ¸¹ÀÌ ³ª¿Â´Ù. Á¶±¹Àº ³í¹® Á¦1ÀúÀÚ ³í¶õ°ú °ü·Ã, ¡°¿ì¸® ¾ÆÀ̰¡ ¿µ¾î¸¦ Á» ÀßÇÏ´Â Æí¡±À̶ó¸ç ¡°¿¬±¸ ¼º°ú¸¦ ¿µ¾î·Î Á¤¸®ÇÏ´Â µ¥ Å« ±â¿©¸¦ Çß´Ù°í Æò°¡ÇÑ °Í °°´Ù¡±°í Çß´Ù. ±×·¡¼­ ³í¹®À» Àо °ÍÀε¥, ³í¹®¿¡¼­ °¡Àå Áß¿äÇÏ´Ù°í ÇÒ ¼ö ÀÖ´Â ÃÊ·Ï(abstract)ÀÇ Ã¹ ¹®ÀåºÎÅÍ ¿ÀŸ°¡ ³ª¿Ô´Ù.

ÃÊ·ÏÀÇ Ã¹ ¹®ÀåÀº ´ÙÀ½°ú °°´Ù.

Background : In perinatal hypoxic-ischemic encephalopathy (HIE), cerebral blood flow is impaired and the activity of nitric oxide systhase (NOS) is markedly increased.

ÀÏ»êÈ­Áú¼Ò ÇÕ¼ºÈ¿¼Ò¸¦ ¶æÇÏ´Â nitric oxide systhase (NOS)¸¦ ½è´Âµ¥ systhase°¡ ¾Æ´Ï¶ó synthaseÀÌ´Ù.

ÃÊ·Ï¿¡´Â ¹®¹ýÀû ¿À·ù°¡ ¿©·µ ½Ç·Á ÀÖ´Ù. °á°ú¸¦ ¼³¸íÇÏ´Â ºÎºÐ¿¡´Â ´ÙÀ½°ú °°Àº ¹®ÀåÀÌ ÀÖ´Ù. ¡°The comparisons between the controls and each subgroups¡¦¡± ¸¶Áö¸· ºÎºÐ¿¡ each°¡ ³ª¿À´Âµ¥ each ´ÙÀ½¿¡´Â Ç×»ó ´Ü¼ö ¸í»ç°¡ µû¶ó¿Í¾ß ÇÑ´Ù. Subgroups°¡ ¾Æ´Ï¶ó subgroupÀ̾î¾ß ÇÑ´Ù. º¹¼öÇüÀÎ subgroups¸¦ ±»ÀÌ ¾²°í ½ÍÀ¸¸é each of°¡ ¾Õ¿¡ ÀÖ¾î¾ß ÇÑ´Ù.

For the association with the development of a strokeÀ̶ó´Â Ç¥Çöµµ ³ª¿À´Âµ¥ ³úÁ¹ÁßÀ» ¶æÇÏ´Â stroke ¾Õ¿¡ ´Ü¼ö¸¦ »ó¡ÇÏ´Â a´Â ÇÊ¿ä ¾ø´Ù. ÀÌ·¸°Ô ÀϹÝÀûÀ¸·Î »ç¿ëÇÒ ¶§´Â a ¾ø´Â strokes°¡ ¸Â´Â´Ù.

³í¹®ÀÇ Ã¹ ÆäÀÌÁö¸¦ ¹ø¿ªÇغôÙ. °³ÀÎÀûÀ¸·Î´Â ¿µ¾î·Îµµ ÀÌÇØ°¡ ¾ÈµÇ°í Çѱ¹¾î·Îµµ ÀÌÇØ°¡ ¾ÈµÆ´Ù. ±×¸¸Å­ Àü¹®ÀûÀÎ ³»¿ëÀÌ´Ù. ±âÀÚ°¡ ¹ø¿ªÇÑ ºÎºÐ°ú ¿µ¹®À» ÇÔ²² ¼Ò°³ÇÑ´Ù.


<¹è°æ: Ãâ»ê ÀüÈÄÀÇ ÇãÇ÷¼º Àú»ê¼Ò³úº´Áõ(HIE) »óȲ¿¡¼­ ´ë³úÀÇ Ç÷·ù´Â ¼Õ»óµÇ°í ÀÏ»êÈ­Áú¼Ò ÇÕ¼ºÈ¿¼Ò´Â Å©°Ô Áõ°¡Çß´Ù. ³úÁ¹ÁßÀ¸·Î ÁøÇàµÇ´Â °Í°ú °ü·Ã, ÀÏ»êÈ­Áú¼ÒÇÕ¼ºÀÇ ´ÙÇü(Òýúþ)Àº Àß ¾Ë·ÁÁ® ÀÖ´Ù.
¹æ¹ý: 37¸íÀÇ HIE ȯ¾Æ¿Í 54¸íÀÇ Á¤»ó ½Å»ý¾ÆÀÇ Á¦ÇÑ È¿¼Ò ¼ÒÈ­¸¦ ÅëÇϰųª ÅëÇÏÁö ¾ÊÀº Æú¸®¸Þ¶ó¾ÆÁ¦ ¿¬¼â ¹ÝÀÀÀ» ºÐ¼®, ¼¼ °¡ÁöÀÇ ÀÓ»óÀûÀÎ ´ÙÇüÀÌ ³ªÅ¸³µ´Ù. À¯ÀüÀÚÇü°ú ´ë¸³ ÇüÁú, ÀϹèüÇü(ìéÛÃô÷úþ)ÀÇ Áֱ⿡ ´ëÇÑ Â÷ÀÌÁ¡Àº Á¶»çÀÚ ±×·ìÀ» ³ª´©¾î Æò°¡µÆ´Ù.
°á°ú: ´ë¸³ ÇüÁú Áֱ⸦ ºÐ¼®ÇÑ °á°ú ÅëÁ¦Áý´Üº¸´Ù HIE Áý´Ü¿¡¼­ Glu298ASPÀÇ G ´ë¸³ ÇüÁúÀÌ ´õ¿í ÀÚÁÖ ÀÖ´Â °ÍÀ» º¼ ¼ö ÀÖ´Ù. HIE¿Í °ü·ÃÇÑ ºñ±³ Áý´Ü ¹× °¢Á¾ ¼¼ºÎ Áý´ÜÀ» ºñ±³ÇÑ °á°ú, ´Ù¸¥ ºñ±³Áý´Üº¸´Ù ½Å»ý¾ÆÀÇ Æó°íÇ÷¾Ð(PPHN) ȯÀÚ¿¡¼­ TC À¯ÀüÀÚÇü°ú T-786CÀÇ C ´ë¸³ ÇüÁúÀÌ ´õ¿í ¸¹ÀÌ ¹ß°ßµÆ´Ù. HIE ȯÀÚÀÇ °æ¿ì ´Ù¸¥ Áý´Ü°ú ºñ±³ÇßÀ» ¶§ A b T ÀϹèüÇü Áֱ⸦ º¸ÀÌ´Â °ÍÀÌ Àû¾ú´Ù.
°á·Ð: Glu298AspÀÇ G ´ë¸³ ÇüÁúÀº Ãâ»ê ÀüÈÄÀÇ HIE¿Í °ü°è°¡ ÀÖ°í TC À¯ÀüÀÚÇü°ú T-786CÀÇ C ´ë¸³ ÇüÁúÀº ½Å»ý¾ÆÀÇ Æó°íÇ÷¾Ð°ú °ü°è°¡ ÀÖ´Ù.

(º»¹®)
»êÈ­Áú¼Ò(NO)´Â ÀÏ»êÈ­Áú¼ÒÇÕ¼ºÈ¿¼Ò¸¦ ÅëÇØ L-¾Æ¸£Áö´ÑÀÌ L-½ÃÆ®·ê¸°À¸·Î »êÈ­µÇ´Â °úÁ¤¿¡¼­ ¹ß»ýÇÑ´Ù. ³»ÇǼ¼Æ÷´Â Ç÷°ü±äÀåµµ¸¦ °ü¸®ÇÏ´Â Áß¿äÇÑ »ý¸®Àû ¿ªÇÒÀ» ÇÏ´Â ³»ÇÇÀÇ ÀÏ»êÈ­Áú¼ÒÇÕ¼ºÀ» ÅëÇØ »êÈ­Áú¼Ò¸¦ ¸¸µé ¼ö ÀÖ´Ù. ¾Æ¿ï·¯, »êÈ­Áú¼Ò´Â ºÎµå·¯¿î ±ÙÀ°¼¼Æ÷ÀÇ È®»êÀ» Á¶ÀýÇÏ°í ³»ÇÇ¿¡ »ý±â´Â ¹éÇ÷±¸Á¢ÇÕÀ» Èñ¼®½Ã۰í, Ç÷¼ÒÆÇÀÀÁýÀ» ¾ïÁ¦ÇÑ´Ù.

Background : In perinatal hypoxic-ischemic encephalopathy (HIE), cerebral blood flow is impaired and the activity of nitric oxide systhase (NOS) is markedly increased. For the association with the development of a stroke, the endothelial NOS (eNOS) polymorphisms are well-known. Methods : Three clinically relevant polymorphisms of the eNOS gene were determined in 37 term/near-term infants with perinatal HIE (HIE group) and 54 normal term newborn infants without any perinatal problems (control group) using a polymerase chain reaction with or without restriction fragment enzyme digestion. The differences in the genotype, allele, and haplotype frequencies were evaluated between the groups. Results : The analysis of the allele frequencies showed that the G allele of Glu298Asp was more frequent in the HIE group than in the controls. The comparisons between the controls and each subgroups with complications that occurred with HIE showed that the TC genotype and C allele of T-786C were more common in patients with persistent pulmonary hypertension of the newborn (PPHN) than in the controls. The frequency of the A b T haplotype was lower in the HIE patients than in the controls. Conclusions : The G allele of Glu298Asp was associated with perinatal HIE, while the TC genotype and C allele of T-786C were associated with PPHN.

Nitric oxide (NO) is produced from the oxidation of L-arginine to L-citrulline by NO synthase (NOS).1 Endothelial cells are able to produce NO via endothelial NOS (eNOS), which has an important physiologic role in regulating vascular tone. Moreover, NO modulates smooth muscle cell proliferation and attenuates leukocyte adhesion to the endothelium, as well as inhibition of platelet aggregation.







  • Æ®À§ÅÍ
  • ÆäÀ̽ººÏ
  • ¡èÀ§·Î
Copyright ¨Ï Á¶°©Á¦´åÄÄ - ¹«´ÜÀüÀç ¹× Àç¹èÆ÷ ±ÝÁö
´ñ±Û´Þ±â ´ñ±Û¾²±â ÁÖÀÇ»çÇ×

´ñ±Û´Þ±â´Â ·Î±×ÀÎÈÄ »ç¿ëÇÏ½Ç ¼ö ÀÖÀ¸¸ç, ³»¿ëÀº 100ÀÚ À̳»·Î Àû¾îÁֽʽÿÀ. ±¤°í, ¿å¼³, ºñ¼Ó¾î, ÀνŰø°Ý°ú ÇØ´ç ±Û°ú °ü·Ã ¾ø´Â ±ÛÀº »çÀüÅ뺸¾øÀÌ »èÁ¦µË´Ï´Ù.

PC ¹öÀü